13F Holdings
中文EN

NPT Texxon Holding Ltd Annual reports only

Wholesale-Chemicals & Allied Products · Nasdaq · SEC CIK 2014337 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-39.3%
TTM net income YoY-420.6%
TTM EPS YoY-360.0%
Revenue 3-yr CAGR-4.3%
Net income 3-yr CAGR—

Margins

Gross margin0.2%
Operating margin-1.7%
Net margin-1.0%
FCF margin-2.7%
EBITDA margin-1.3%

Returns

ROE-176.4%
ROA-3.2%
ROIC (approx.)-16.6%
Asset turnover3.18x

Leverage & solvency

Liabilities / assets65.1%
Debt / equity4.51x
Current ratio0.45x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.36x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue3.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20262026-06-30FY20252025-06-30FY20242024-06-30FY20232023-06-30
Income statement
Revenue$484.04M$797.15M$672.66M$552.53M
Cost of revenue$482.94M$792.45M$667.85M$548.99M
Gross profit$1.10M$4.70M$4.82M$3.53M
SG&A expense$7.35M$2.89M$2.17M$1.28M
Operating income-$8.08M-$600,646$659,969$1.25M
Pretax income-$8.99M-$737,235$3.23M$2.13M
Income tax$0$716,897$716,782$42,998
Net income-$4.86M-$932,621$953,560$2.02M
EBITDA-$6.45M-$312,574$992,697$1.51M
EPS (basic)-0.23-0.050.050.10
EPS (diluted)-0.23-0.050.050.10
Weighted avg. shares (diluted)21.50M20.00M20.00M20.00M
Balance sheet
Cash & equivalents$94,101$2.52M$272,895$12.18M
Receivables$1.10M$7.52M$11.09M—
Inventory$2.01M$973,644$667.61M$548.79M
Current assets$35.06M$20.76M$18.05M—
PP&E, net$121.11M$84.62M$23.36M—
Intangibles$6.79M$6.16M$6.21M—
Total assets$165.24M$138.97M$89.70M$74.91M
Current liabilities$77.79M$72.74M$57.32M—
Short-term debt$12.26M$0$25.79M—
Long-term debt$29.75M$32.18M$25.79M—
Total debt$42.02M$32.18M$51.58M—
Total liabilities$107.60M$104.92M$57.32M—
Shareholders' equity$9.32M-$3.81M-$2.85M$33.08M
Net debt$41.92M$29.66M$51.30M—
Shares outstanding22.18M20.00M20.00M—
Cash flow statement
Operating cash flow$1.76M$2.32M-$30.80M-$14.18M
Capital expenditure$14.77M$45.10M$33.34M$22.62M
Free cash flow-$13.01M-$42.78M-$64.13M-$36.80M
Investing cash flow-$15.03M-$42.25M-$11.02M-$41.23M
Financing cash flow$10.39M$41.36M$29.36M$30.41M
Depreciation & amortization$1.63M$288,072$332,728$251,081

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.